Clinical trials
Active, not recruiting Phase 2 Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tanta University | 2 |
| Aphaia Pharma US LLC | 1 |
| Gannex Pharma Co., Ltd. | 1 |
| GlaxoSmithKline | 1 |
| Guangdong Raynovent Biotech Co., Ltd | 1 |
| Mayo Clinic | 1 |
| MediciNova | 1 |
| Northwestern University | 1 |
| Rivus Pharmaceuticals, Inc. | 1 |
| University of California, San Diego | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 15 |
| Diabetes Mellitus, Type 2 | 2 |
| Fatty Liver | 2 |
| Carcinoma, Hepatocellular | 1 |
| Endocrine System Diseases | 1 |
| Glucose Intolerance | 1 |
| Hypertension | 1 |
| Hypertriglyceridemia | 1 |
| Hyperuricemia | 1 |
| Liver Cirrhosis | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.